Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
JNJ received a not approvable letter from FDA for an NDA for Zarnestra tipifarnib to treat elderly patients with newly diagnosed acute myeloid leukemia (AML). The company will review the letter to det...
